HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Diagnosis and treatment of community-acquired and hospital-acquired pneumonia.

Abstract
The older drugs used to treat pneumonia may still be useful in self-limiting infections. Newer antibiotics--augmented penicillins, trimethoprim-sulfamethoxazole, third-generation cephalosporins, and others--are quite effective, but resistance can be a problem, and some patients cannot tolerate the adverse events associated with these agents. The fluoroquinolones are effective in treating pneumonia because of their broad spectra of activity against gram-negative and gram-positive organisms, including Streptococcus pneumoniae and Haemophilus influenzae. They are rapidly and nearly completely absorbed after oral administration; bioavailability ranges up to 100% for ofloxacin and lomefloxacin. Concentrations attained in lung tissues and sputum generally exceed the minimum inhibitory concentrations for the most common respiratory tract pathogens. The quinolones are also well tolerated; most adverse events are mild and do not lead to discontinuation of therapy. Ciprofloxacin and ofloxacin are available in parenteral as well as oral formulations. The high bioavailability of oral ofloxacin (> 95%) allows a patient to be started on the parenteral form in the hospital and continued taking the oral form at home with no loss of efficacy, but with reduced costs and improved quality of life.
AuthorsM T Foster Jr
JournalPharmacotherapy (Pharmacotherapy) 1993 Mar-Apr Vol. 13 Issue 2 Pt 2 Pg. 45S-50S ISSN: 0277-0008 [Print] United States
PMID8474938 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Anti-Bacterial Agents
  • Anti-Infective Agents
  • Fluoroquinolones
Topics
  • Anti-Bacterial Agents (therapeutic use)
  • Anti-Infective Agents (adverse effects, pharmacology, therapeutic use)
  • Bacterial Infections (diagnosis, drug therapy)
  • Cross Infection (diagnosis, drug therapy)
  • Drug Resistance, Microbial
  • Fluoroquinolones
  • Gram-Negative Bacteria (drug effects)
  • Gram-Positive Bacteria (drug effects)
  • Humans
  • Pneumonia (diagnosis, drug therapy, etiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: